---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-21-342427"
form_type: "8-K"
ticker: "BIO"
cik: "0000012208"
company_name: "BIO-RAD LABORATORIES, INC."
filed_at: "2021-11-29T23:59:59+00:00"
generated_at: "2026-06-28T05:04:10.013152+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Bio-Rad loans €400M to Sartorius-Herbst at 1.5% plus appreciation rights

## Summary
- Loan of €400 million to Sartorius-Herbst Beteiligungen II GmbH at 1.5% per annum plus value appreciation rights.
- Maturity on January 31, 2029, subject to early termination provisions.
- Proceeds used to partially finance acquisition of interests under the Sartorius Trust from another beneficiary.
- Loan collateralized by pledge of trust interests under the Sartorius Trust.

## SEC filing metadata
- accession: 0001193125-21-342427
- form_type: 8-K
- ticker: BIO
- cik: 0000012208
- company_name: BIO-RAD LABORATORIES, INC.
- filed_at: 2021-11-29T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 8.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/12208/000119312521342427/0001193125-21-342427-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/12208/000119312521342427/d271505d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-21-342427
- JSON: https://secwatch.observer/filing/0001193125-21-342427.json
- Plain text: https://secwatch.observer/filing/0001193125-21-342427.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.